In this study, we investigated the presence and properties of anti-insulin antibodies (IAs) in patients with T1D and T2D to determine if IAs and/or different isotypes and subclasses of IAs affect the efficacy of insulin therapy on glycemic control. This evidence concerns the gene INS and type 2 diabetes mellitus.